Sheng-Jie Yu Selected Research

Dermatophagoides pteronyssinus antigen p 2

1/2015	Cell-penetrating peptide derived from human eosinophil cationic protein inhibits mite allergen Der p 2 induced inflammasome activation.
12/2014	Der p 2 can induce bystander activation of B cells derived from patients with systemic lupus erythematosus.
10/2014	House dust mite allergy: environment evaluation and disease prevention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheng-Jie Yu Research Topics

Disease

7	Inflammation (Inflammations) 01/2021 - 10/2014
6	Hypersensitivity (Allergy) 01/2021 - 10/2014
4	Neoplasms (Cancer) 02/2022 - 05/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 06/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 12/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2022
1	Disease Progression 02/2022
1	Dermatitis 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Colonic Neoplasms (Colon Cancer) 11/2021
1	Immediate Hypersensitivity 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Allergic Rhinitis 01/2020
1	Nasopharyngeal Carcinoma 01/2019
1	Dust Mite Allergy 01/2018
1	Asthma (Bronchial Asthma) 01/2015
1	Mite Infestations (Mange) 10/2014

Drug/Important Bio-Agent (IBA)

5	AllergensIBA 01/2021 - 12/2014
3	Immunoglobulin E (IgE)IBA 09/2020 - 10/2014
3	CytokinesIBA 01/2020 - 10/2014
3	Dermatophagoides pteronyssinus antigen p 2IBA 01/2015 - 10/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 06/2019
2	Pharmaceutical PreparationsIBA 11/2021 - 01/2020
1	Niclosamide FDA Link 02/2022
1	Therapeutic UsesIBA 01/2022
1	forsythiasideIBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Itraconazole (Sporanox)FDA LinkGeneric 11/2021
1	TransketolaseIBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	P-2 (P 2)IBA 09/2020
1	Complex MixturesIBA 09/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 07/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	shikoninIBA 01/2020
1	ChemokinesIBA 01/2020
1	LuteolinIBA 01/2020
1	Qingdai compoundIBA 06/2019
1	Indigo Carmine (Indigo Blue)IBA 06/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	InflammasomesIBA 01/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	Monoclonal AntibodiesIBA 10/2014
1	Dermatophagoides pteronyssinus antigen p 1IBA 10/2014
1	Immunoglobulin A (IgA)IBA 10/2014
1	Pattern Recognition ReceptorsIBA 10/2014

Therapy/Procedure

2	Immunotherapy 01/2018 - 01/2015
1	Drug Therapy (Chemotherapy) 07/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2019
1	Therapeutics 01/2019
1	Oral Administration 01/2019
1	Chemoradiotherapy 05/2018
1	Immunomodulation 10/2014